Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
Vaccination against SARS-CoV-2 remains critical for control of the Covid-19 pandemic. A pathogenic PF4-dependent syndrome, unrelated to the use of heparin therapy, can occur after the administration of the ChAdOx1 nCoV-19 vaccine. Rapid identification of this rare syndrome is important because of the therapeutic implications.
2021-04-16
没有评论